Author: user

[ad_1] KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (the “Tender Offeror”) hereby announces that (i) at the meeting of the Board of Directors held on December 26, 2024, it is resolved that the Tender Offeror will acquire the shares of Makino Milling Machine Co., Ltd. (the ” Target (NYSE:) Company”), which is listed on the Prime Market of the Tokyo Stock Exchange, Inc., as part of a series of transactions (the ” Transaction (JO:)”) for the purpose of making the Target Company a wholly owned subsidiary of the Tender Offeror. The Company resolved to acquire the shares of common stock of the Target…

Read More

[ad_1] (Bloomberg) — Bitcoin’s record-breaking rally is rekindling hope that the digital-ledger technology that underpins cryptocurrencies will revolutionize everything from recording the ownership of houses to bonds. Most Read from Bloomberg Tokenization, or the process of creating digital representations of real-world assets on a blockchain, has become one of this year’s buzzwords in both conventional and crypto finance circles. The excitement is reminiscent of the hype of a few years ago surrounding the use of blockchains for everything from tracking lettuce at Walmart Inc. to digitizing stocks that proved to be premature. For years now, tokenization of assets beyond stablecoins…

Read More

[ad_1] Philadelphia, Pennsylvania–(Newsfile Corp. – December 27, 2024) – Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) on behalf of purchasers of ASP Isotopes securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”). Investors that suffered losses from ASP ISOTOPES (NASDAQ: ASPI) investments can follow the link below for more information regarding the lawsuit:CLICK HERE to learn more about the lawsuit. Investors who purchased or acquired ASP ISOTOPES securities during the Class Period may, no later than FEBRUARY 3,…

Read More

[ad_1] Ric Smith, President of Product, Technology & Operations at SentinelOne , Inc. (NYNYSE:E:S), has made notable transactions involving the company’s stock. On December 26, 2024, Smith sold 14,583 shares of Class A Common Stock at a weighted average price of $22.7536, totaling approximately $331,815. This sale was executed under a Rule 10b5-1 trading plan, which was adopted earlier in the year. Additionally, Smith acquired 14,583 shares of Class A Common Stock through the conversion of Class B stock, with the shares priced at $9.74 each, amounting to a total value of $142,038. Following these transactions, Smith holds 531,459 shares…

Read More

[ad_1] Mark David Brazeal, Chief Legal and Corporate Affairs Officer at Broadcom Inc. (NASDAQ:), recently sold 20,168 shares of the company’s common stock. The transaction, which took place on December 24, 2024, was executed at prices ranging from $238.77 to $238.88 per share, resulting in a total sale value of approximately $4.8 million. This sale comes as Broadcom, now valued at $1.13 trillion, trades near its 52-week high of $251.88, having delivered an impressive 119% return year-to-date. According to InvestingPro analysis, the stock appears overvalued at current levels. Following this sale, Brazeal retains ownership of 321,660 shares, which includes 263,750…

Read More

[ad_1] David Alan Campbell, President and CEO of Janux Therapeutics, Inc. (NASDAQ:JANX), recently sold 25,000 shares of the company’s common stock. The transaction, which took place on December 24, 2024, was executed under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $56.1922, resulting in a total transaction value of approximately $1.4 million. Following the sale, Campbell retains ownership of 217,054 shares in the company, which represents a significant stake in the $2.9 billion market cap biotech firm.This insider transaction comes amid a remarkable year for Janux, with the stock posting a 404% gain…

Read More

[ad_1] (Photo: Jim Allen & Grace Sharkey/FreightWaves) This year freight fraud took center stage, exposing cracks in the logistics industry’s defenses and leaving a trail of financial devastation. From coordinated ransom schemes to pandemic relief fraud, 2024 showcased the growing sophistication and reach of bad actors in transportation. These cases revealed a troubling pattern of exploiting systemic vulnerabilities. Fraudsters used tools like falsified documents, illegal carriers and shell companies to bypass regulations and manipulate financial systems. The industry saw brokers, carriers and investors fall victim to schemes that spanned everything from Ponzi operations to digital freight mismanagement. Coordinated attacks, such…

Read More

[ad_1] New York, New York–(Newsfile Corp. – December 27, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ASP Isotopes Inc. (NASDAQ: ASPI) between October 30, 2024 and November 26, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased ASP Isotopes securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the ASP Isotopes class action, go to…

Read More

[ad_1] U.S. President-elect Donald Trump attends Turning Point USA’s AmericaFest in Phoenix, Arizona, U.S., December 22, 2024. Cheney Orr | ReutersPresident-elect Donald Trump on Friday asked the Supreme Court to pause implementation of a law that would ban TikTok in the U.S. on Jan. 19 if the app is not sold by its Chinese parent company.The court is due to hear arguments in the case on Jan. 10.”President Trump takes no position on the underlying merits of this dispute,” wrote D. John Sauer, Trump’s lawyer who is also the president-elect’s pick for U.S. solicitor general. “Instead, he respectfully requests that the Court consider staying the…

Read More

[ad_1] New York, New York–(Newsfile Corp. – December 27, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between February 28, 2022 and November 6, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025 lead plaintiff deadline. SO WHAT: If you purchased Dentsply Sirona common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Dentsply Sirona class action,…

Read More